View Author
virus fluenza infection influenza epitope vaccine fluenza virus response antibody group donor hla-a fluenza viruses hla-b immunity animal peptide strain influenza virus titer vaccination assay variant virus-specific study mva-ha-vn clone immunization cytotoxic virol target cells children stimulation /04 mva-ha-vn /04 target rimmelzwaan pandemic control avidity vaccinia iav hk /68 h 5n viruses /h viruses frequency c 1r cells number replication cross-reactive immunol subtype allele challenge infection challenge netherland recognition ctl response table population osterhau virus replication subject iav ind /05 cytotoxic t lymphocytes ctl epitopes wtmva protection protein expression fluenza b viruses heterosubtypic immunity weight serum samples heterosubtypic difference presence percentage antigen speci ankara
10 Most Recent Publications
|
Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands
(Article)
Bodewes, R. Mutsert, G. de Klis, F.R. van der Ventresca, M. Wilks, S. Smith, D.J. Koopmans, M. Fouchier, R.A.M. Osterhaus, A.D.M.E. Rimmelzwaan, G.F. |
2011-03-01
|
|
Evaluation of a modified vaccinia virus Ankara (MVA)-based candidate pandemic influenza A/H1N1 vaccine in the ferret model
(Article)
Kreijtz, J.H.C.M. Süzer, Y. Fouchier, R.A.M. Osterhaus, A.D.M.E. Sutter, G. Rimmelzwaan, G.F. Bodewes, R. Schwantes, A. Amerongen, G. van Verburgh, R.J. Mutsert, G. de Brand, J. van den Trierum, S.E. Kuiken, T. |
2010-11-01
|
|
MVA-based H5N1 vaccine affords cross-clade protection in mice against influenz a A/H5N1 viruses at low doses and after single immunization
(Article)
Kreijtz, J.H.C.M. Suezer, Y. Rimmelzwaan, G.F. Mutsert, G. de Amerongen, G. van Scwantes, A. Brand, J.M.A. van den Fouchier, R.A.M. Löwer, J. Osterhaus, A.D.M.E. Sutter, G. |
2009-11-12
|
|
Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses
(Article)
Kreijtz, J.H.C.M. Suezer, Y. Sutter, G. Rimmelzwaan, G.F. Mutsert, G. de Brand, J.M.A. van den Amerongen, G. van Schnierle, B.S. Kuiken, T. Fouchier, R.A.M. Löwer, J. Osterhaus, A.D.M.E. |
2009-10-23
|
|
Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus
(Article)
Kreijtz, J.H.C.M. Bodewes, R. Brand, J.M.A. van den Mutsert, G. de Baas, C. Amerongen, G. van Fouchier, R.A.M. Osterhaus, A.D.M.E. Rimmelzwaan, G.F. |
2009-08-06
|
|
Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus
(Article)
Bodewes, R. Kreijtz, J.H.C.M. Baas, C. Geelhoed-Mieras, M.M. Mutsert, G. de Amerongen, G. van Brand, J.M.A. van den Fouchier, R.A.M. Osterhaus, A.D.M.E. Rimmelzwaan, G.F. |
2009-05-14
|
|
Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques
(Article)
Kreijtz, J.H.C.M. Suezer, Y. Sutter, G. Rimmelzwaan, G.F. Mutsert, G. de Brand, J.M.A. van den Amerongen, G. van Schnierle, B.S. Kuiken, T. Fouchier, R.A.M. Löwer, J. Osterhaus, A.D.M.E. |
2009-02-01
|
|
Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus
(Article)
Kreijtz, J.H.C.M. Mutsert, G. de Baalen, C.A. van Fouchier, R.A.M. Osterhaus, A.D.M.E. Rimmelzwaan, G.F. |
2008-06-01
|
|
Attachment of infectious influenza A viruses of various subtypes to live mammalian and avian cells as measured by flow cytometry
(Article)
Rimmelzwaan, G.F. Nieuwkoop, N. Mutsert, G. de Boon, A.C.M. Kuiken, T. Fouchier, R.A.M. Osterhaus, A.D.M.E. |
2007-11-01
|
|
Recombinant modified vaccinia virus ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1
(Article)
Kreijtz, J.H.C.M. Suezer, Y. Sutter, G. Rimmelzwaan, G.F. Amerongen, G. van Mutsert, G. de Schnierle, B.S. Wood, J.M. Kuiken, T. Fouchier, R.A.M. Löwer, J. Osterhaus, A.D.M.E. |
2007-06-01
|
